HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) All Versions of this Article: 0091270008315956v1 48/6/719    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, J. Articles by D'Argenio, D. Z. Search for Related Content PubMed PubMed Citation Articles by Wang, J. Articles by D'Argenio, D. Z. Social Bookmarking                   What's this?

A Note on Population Analysis of Dissolution-Absorption Models Using the Inverse Gaussian Function

From the Department of Biomedical Engineering, University of Southern California, Los Angeles (Dr Wang, Dr D'Argenio) and the Section of Pharmacokinetics, Department of Pharmacology, Martin Luther University, Halle-Wittenberg, Germany (Dr Weiss).

Because conventional absorption models often fail to describe plasma concentration–time profiles following oral administration, empirical input functions such as the inverse Gaussian function have been successfully used. The purpose of this note is to extend this model by adding a first-order absorption process and to demonstrate the application of population analysis using maximum likelihood estimation via the EM algorithm (implemented in ADAPT 5). In one example, the analysis of bioavailability data of an extended-release formulation, as well as the mean dissolution times estimated in vivo and in vitro with the use of the inverse Gaussian function, is well in accordance, suggesting that the inverse Gaussian function indeed accounts for the in vivo dissolution process. In the other example, the kinetics of trapidil in patients with liver disease, the absorption/dissolution parameters are characterized by a high interindividual variability. Adding a first-order absorption process to the inverse Gaussian function improved the fit in both cases.

Key Words: Bioavailability • drug absorption • extended release • population pharmacokinetics • ADAPT

Address for reprints: David D'Argenio, PhD, Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, DRB 140, Los Angeles, CA 90089; e-mail: dargenio{at}bmsr.usc.edu.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?